Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alternative Surveillance Program for Prospective Cohort of a Super-high Risk Group of Developing HCC

NCT05657249 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05657249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05657249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alternative Surveillance Program for Prospective Cohort of a Super-high Risk Group of Developing HCC
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 6, 2023
Completion date
December 31, 2026
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma